Skip to main content

Client News

iOmx to Present New Pre-Clinical Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 2022

7th April 2022

Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis

6th April 2022

ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target

6th April 2022

Newron announces AGM 2022 results

5th April 2022

InflaRx Announces Encouraging Phase III Topline Results from PANAMO Trial of Vilobelimab in Severe COVID-19 Patients

31st March 2022

Data on the antimicrobial activity of XF-73 against bacteria within biofilms to be presented at prestigious 2022 ECCMID Congress

31st March 2022

HepaRegeniX appoints Elias Papatheodorou as new Chairman of the Board of Directors

30th March 2022

Adocia strengthens its cash position by 19 million euros following a real estate transaction

28th March 2022

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

28th March 2022

InflaRx Reports Full Year 2021 Financial and Operating Results

24th March 2022